Axsome Therapeutics, Inc.
AXSM
$148.30
$0.490.33%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/4/2025
-
MarketBeat
12/4/2025
-
MarketBeat
12/3/2025
-
Tickeron - Stocks
12/3/2025
-
Zacks Investment Research
Granite Investment Partners LLC Has $13.42 Million Stock Position in Axsome Therapeutics, Inc. $AXSM
12/3/2025
-
MarketBeat
12/2/2025
-
Tickeron - Stocks
12/2/2025
-
Fool.com Headlines
12/1/2025
-
MarketBeat
12/1/2025
-
MarketBeat
12/1/2025
-
MarketBeat
11/29/2025
-
MarketBeat
11/28/2025
-
MarketBeat
11/26/2025
-
MarketBeat
11/25/2025
-
MarketBeat
11/24/2025
-
Ticker Report
11/24/2025
-
MarketBeat
11/24/2025
-
MarketBeat
11/24/2025
-
MarketBeat
11/24/2025
-
MarketBeat
11/22/2025
-
Tickeron - Stocks
11/21/2025
-
Tickeron - Stocks
11/20/2025
-
GuruFocus
11/20/2025
-
Globe Newswire
Axsome Therapeutics (AXSM, $145.56) price may drop as it broke higher Bollinger Band on Nov 17, 2025
11/18/2025
-
Tickeron - Stocks
11/18/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 3, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
212 332 3241
Address
One World Trade Center
New York, NY 10007
New York, NY 10007
Country
Year Founded
Business Description
Sector
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company’s...
more